Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative bevacizumab for tractional retinal detachment in PDR
NCT01976923Phase 3Completed
- Start
- Nov 2013
- Primary completion
- Jul 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in Tractional retinal detachment (TRD). Started Nov 2013; status: completed.
02
Drugs
bevacizumab
03
Conditions
Tractional retinal detachment (TRD)
Beyond the preview
Go deeper on NCT01976923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01976923.